Growth curves also showed that GIT1 knockdown and overexpression had a profound effect on tumour growth rates in vivo (Fig. 5d–f; doubling time: 2.60-fold increase for GIT1-mRFP, 2.16-fold decrease for GIT1-shRNA3). Here, GIT1 is linked to neoplasm.